

eLAMP – A novel electronic diagnostic test for bacteria and viruses has been created by researchers at the University of Surrey.
The researchers, led by Professor Johnjoe McFadden, created an electronic diagnostic test known as ‘Electro-chemical LAMP’ (eLAMP). The new test is inexpensive, quick, and sensitive.
eLAMP has the sensitivity of laboratory-based PCR testing but can be conducted at home using a smartphone.
How does the new diagnostic test work?
eLAMP converts the output of a PCR-like test called LAMP into a simple electric current. The diagnostic test device is small and has the potential to be miniaturized into a simple memory-stick-sized device that anyone with an app could operate.
The test can be performed at home because the device is tiny. The result can then be quickly relayed to health professionals to track the progress of infection and provide timely guidance to the patient.
Professor Johnjoe McFadden, corresponding author of the study and Professor of Molecular Genetics at the University of Surrey, said: “A key lesson we took from the COVID-19 pandemic is how crucial rapid, effective and cheap diagnostic tools that can be used at home are to monitoring and containing infectious diseases.
“Our test meets these criteria and can detect lower amounts of the SARS-CoV-2 virus compared to other home-based tests.
“We are looking for commercial partners to further develop the test and take it to market.”
Benefits of the test
The researchers tested human blood, saliva, and swabs from the nose and throat and discovered that their test was 93.33% accurate.
They discovered that the test works effectively at room temperature, with results available after 45 minutes.
It is critical to develop more effective coronavirus testing methods.
Since the World Health Organization declared SARS-CoV-2 a global pandemic in 2020, about six million people have died, and approximately two million cases are recorded globally every day.
The virus generally affects people’s lungs. Coughing, fever, and difficulty breathing are all symptoms. It can cause cardiac difficulties and organ failure in severe cases.
Dr Khushboo Borah Slater, co-author of the study from the University of Surrey, said: “SARS-CoV-2 is likely to be around for a long time and, unfortunately, new difficult viruses are likely to emerge.
“It’s crucial to keep working on better ways to test for the coronavirus, and our goal is to further develop our diagnostic test so that it can be easily used everywhere to help control the disease and prevent future outbreaks.”
For more details: Development of a loop-mediated isothermal amplification (LAMP)-based electrochemical test for rapid detection of SARS-CoV-2
https://doi.org/10.1016/j.isci.2023.107570
more recommended stories
Philippines Strengthens ASF Detection and Control
Innovative Solutions for Rapid ASF Detection.
Key Immune Pathways in Centenarians Identified
Centenarians Offer Clues to Healthy Aging.
Bee-Sting Microneedle Patch for Painless Drug Delivery
Microneedle Patch: A Pain-Free Alternative for.
Action Video Games and Brain Health: Study Insights
Gaming and Brain Structure: What MRI.
Creatine May Boost Muscle Strength in Alzheimer’s Patients
Creatine Supplementation Shows Promise in Alzheimer’s.
New Drug STF-1623 Shows Promise in Treating Solid Tumors
STF-1623 Transforming ‘Cold’ Tumors into ‘Hot’.
AI Reshapes Anticoagulation in Atrial Fibrillation Care
Understanding the Challenge of Atrial Fibrillation.
Macrophage Microautophagy Supports Immune Readiness
A Breakthrough in Cellular Recycling Macrophages,.
The Role of α-Glucosidase in Type 2 Diabetes
α-Glucosidase Inhibition: Functional Food Compounds for.
Oral Bacteria Linked to Atherosclerosis
New Evidence Links Viridans Streptococci to.
Leave a Comment